AstraZeneca's CEO said on Tuesday that the company's China president Leon Wang, who last month was detained by Chinese ...

AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to ...

Despite China’s investigations into insurance fraud, allegedly illegal importation of unapproved drugs and improper ...

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

London-listed drugmaker AstraZeneca said its plan to invest 450 million pounds ($576.7 million) in Britain for vaccine ...

Additionally, it will also increase its cell therapy manufacturing capacity on the West and East Coasts. Pascal Soriot, CEO ...

AstraZeneca Plc isn’t the only health-care company facing compliance questions in China as concern continued to swirl about a ...

AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...

Q: How might the upcoming US Presidential election impact AstraZeneca's business, and is there a strategic shift towards more ...

Reports Q3 revenue $13.6B, consensus $13.09B. Pascal Soriot, CEO, AstraZeneca (AZN), commenting on the results said: “Our company has ...

Reports Q3 revenue $13.57B, consensus $13.09B. Reports Q3 core EPS $2.08. Pascal Soriot, CEO, AstraZeneca (AZN), said: “Our company has continued on its strong growth trajectory in the first nine ...

CEO of AstraZeneca Pascal Soriot (Justin Tallis/PA) PA Wire In its third quarter update on Tuesday, chief executive Pascal ...